Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways - Xiaodong Li; Ningbo Pang; Yingcong Chen; Tingting Pan; Wenwen Sun; Bingrong Chen; Fuyi Xie; Yinyu Mu; Ni Li (Apoptosis, 2026)